In bladder cancer and hepatocellular carcinoma, tumor cell proliferation and migration are inhibited by CLCA4 through the PI3K/AKT signalling pathway (Hou et al., 2017; Liu et al., 2018). Here, AKT1 is linked to urinary bladder carcinoma.